Last reviewed · How we verify
NCT07017920
Vitamin D and Hypertensive Disorders of Pregnancy
NA trial testing Vitamin D Levels measurement in Hypertensive Disorders of Pregnancy in 594 participants. Not yet recruiting.
1 July 2027
Quick facts
| Lead sponsor | TriHealth Inc. |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 594 |
| Start date | 1 July 2025 |
| Primary completion | 1 July 2027 |
| Estimated completion | 31 December 2027 |
Drugs / interventions tested
- Vitamin D Levels measurement
Conditions studied
- Hypertensive Disorders of Pregnancy — all drugs for Hypertensive Disorders of Pregnancy →
Sponsor
TriHealth Inc. — full company profile →
Who can join
Adults 18 to 45, female only, with Hypertensive Disorders of Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to further investigate the association between vitamin D deficiency/insufficiency and hypertensive disorders of pregnancy by studying the impact of screening for vitamin D deficiency and supplementation when low levels of vitamin D are detected. Screening for vitamin D deficiency (less than 20 ng/mL) and insufficiency (less than 30 ng/mL) may determine the need for additional supplementation, as most prenatal vitamins only contain 400 IU of vitamin D. The rates of hypertensive disorders of pregnancy amongst patients who received supplementation and maintained adequate vitamin D levels will be followed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07017920
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertensive Disorders of Pregnancy
Currently open trials in the same condition.
- NCT07349277 — Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Pree · recruiting
- NCT06632379 — AtorvaStatin Postpartum and Reduction of Cardiovascular risK · Phase 4 · recruiting
- NCT07263490 — PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) · recruiting
- NCT06468202 — Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL · Phase 4 · recruiting
Other TriHealth Inc. trials
Trials by the same sponsor.
- NCT06843538 — Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery · Phase 3 · recruiting
- NCT06958003 — Neonatal Intensive Care Unit (NICU) Diaper Dermatitis: Prevention and Treatment With Airtime · NA · enrolling by invitation
- NCT06957990 — Evaluation of Music Therapy for Pre-op/Intra-op During Hernia Surgery to Decrease the Need for Narcotics · NA · enrolling by invitation
- NCT06414083 — Histologic Comparison of Ablative Techniques for Endometriosis · NA · recruiting
- NCT06252714 — Impact of Defecation Posture on Ease of Bowel Movements in Patients With a Rectocele · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07017920 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TriHealth Inc.
- Last refreshed: 12 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07017920.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing